Current Radiopharmaceuticals
Volume 14, 4 Issues, 2021
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
Contents
Current Radiopharmaceuticals, Volume 4 - Number 2
Radiotracers Based on Technetium-94m
, 4(2): 90 - 101Katherine Gagnon, Steve McQuarrie, Doug Abrams, Alexander J. McEwan and Frank Wuest
DOI: 10.2174/1874471011104020090
The Unrealized Potential of 34mCl for Radiopharmaceutical Research with PET
, 4(2): 102 - 108Jonathan W. Engle, Todd E. Barnhart, Gregory W. Severin and Robert J. Nickles
DOI: 10.2174/1874471011104020102
Recent Advances in Copper Radiopharmaceuticals
, 4(2): 109 - 121Guiyang Hao, Ajay N. Singh, Orhan K. Oz and Xiankai Sun
DOI: 10.2174/1874471011104020109
PET Tracers Based on 86Y
, 4(2): 122 - 130Jinming Huang, Liyang Cui, Fan Wang and Zhaofei Liu
DOI: 10.2174/1874471011104020122
PET Tracers Based on Zirconium-89
, 4(2): 131 - 139Yin Zhang, Hao Hong and Weibo Cai
DOI: 10.2174/1874471011104020131
Nanoradiopharmaceuticals: Is that the Future for Nuclear Medicine?
, 4(2): 140 - 143Ralph Santos-Oliveira
DOI: 10.2174/1874471011104020140
An Optimised Radiolabel Procedure to Prepare 99mTc-Colloidal Rhenium Sulphide to Improve Radiochemical Purity
, 4(2): 144 - 149Benoit Hosten, Romain Roche, Emmanuelle Barre, Julien Fouque, Yvan Mouraeff, Agnes Dumont, Catherine LE Meur, Helene Garrigue, Sabrina Hassoun, Valerie Nataf, Corinne Smadja, Virginie de Beco, Karine Felice and Nathalie Rizzo-Padoin
DOI: 10.2174/1874471011104020144
Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model
, 4(2): 150 - 160Haladhar D. Sarma, Tapas Das, Sharmila Banerjee, Meera Venkatesh, Pandit B. Vidyasagar and Kaushala P. Mishra
DOI: 10.2174/1874471011104020150
Comparison of Three Radiochemical Purity Control Methods of 99mTc-macroaggregated Albumin
, 4(2): 161 - 166Francois Hallouard, Adeline Paul and Marc Fraysse
DOI: 10.2174/1874471011104020161
Relative Hypermetabolism of Vermis Cerebelli in Traumatic Brain Injured Patients Studied with 18FDG PET: A Descriptor of Brain Damage and a Possible Predictor of Outcome
, 4(2): 167 - 175Andrea Lupi, Giannettore Bertagnoni, Anna Borghero, Matteo Salgarello and Pierluigi Zanco
DOI: 10.2174/1874471011104020167
Editor-in-Chief
Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)
Biography
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Biography
Biography of Sean L. Kitson
Dr Kitson is an Investigator of Radiochemistry at Almac, UK. He has over 15 years of experience in the synthesis of carbon-14 labelled compounds. Dr Kitson is the Editor-in-Chief of Current Radiopharmaceuticals published by Bentham Science Publishers and the Journal of Diagnostic Imaging in Therapy. He has published over 45 research, reviews and commercial articles in the area of carbon-14 synthesis and medical imaging. His contribution to radiochemistry was acknowledged by winning the 2006 Wiley Journal of Labelled Compounds and Radiopharmaceuticals Young Scientists Award. Since, 2007 he has been a Member of the Scientific Committee for the International Isotopes Society (IIS) UK group.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net